Benzylmorphine

benzylmorphine

Benzylmorphine is a semi-synthetic opioid narcotic introduced to the market in the early 20th century. It is derived from morphine, where the phenolic hydroxyl group has been replaced by a benzyl group, significantly altering its pharmacological properties. Benzylmorphine is known by various names, including peronine when it was first marketed. It is less potent than morphine but more potent than codeine, making it an intermediate in strength among opioid analgesics.

Chemistry

Benzylmorphine, chemically known as 3-benzylmorphine, is a modification of morphine where a benzyl group is attached to the nitrogen atom of the morphine molecule. This structural modification results in a compound with unique pharmacokinetic and pharmacodynamic properties compared to its parent compound, morphine.

Pharmacology

The pharmacological action of benzylmorphine is primarily as a moderate to strong agonist of the mu-opioid receptor, which is responsible for its analgesic effects. Its affinity for the mu-opioid receptor is lower than that of morphine but higher than that of codeine, placing its efficacy in pain relief between these two well-known analgesics. Benzylmorphine also exhibits cough suppressant properties similar to codeine, making it useful in treating coughs, though it is not commonly used for this purpose today.

Medical Use

Historically, benzylmorphine was used for its analgesic and antitussive (cough suppressant) properties. However, due to its potential for abuse and the development of more effective and safer analgesics, its medical use has significantly declined. Today, benzylmorphine is rarely prescribed or used in clinical practice.

Legal Status

The legal status of benzylmorphine varies by country, but it is generally classified as a controlled substance due to its potential for abuse and addiction. In many jurisdictions, it is listed under schedules that restrict its availability and prescribe its use to specific, tightly regulated medical scenarios.

Abuse and Addiction

Like other opioids, benzylmorphine has the potential for abuse and addiction. Its psychoactive effects can lead to physical dependence and psychological addiction, with users seeking the drug for its euphoric properties rather than its therapeutic effects. The risk of overdose and opioid-related adverse effects further complicates the abuse potential of benzylmorphine.

Conclusion

While benzylmorphine played a role in the development of opioid analgesics, its use today is limited due to the availability of safer, more effective alternatives. Its history underscores the ongoing challenge in balancing the therapeutic benefits of opioids against their potential for abuse and harm.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian